Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Gurunathan · SciRah

Researcher profile · Semantic Scholar

S. Gurunathan

Share profile

S. Gurunathan — researcher profile on SciRah

h-index: 38
Works: 75
Citations: 11K

Most-cited papers

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.
S. Rerks-Ngarm, P. Pitisuttithum, S. Nitayaphan, J. Kaewkungwal +20 more
2009New England Journal of Medicine3,107 citations Open access
Semantic Scholar
DNA vaccines: immunology, application, and optimization*.
S. Gurunathan, D. Klinman, R. Seder
2000Annual Review of Immunology1,296 citations
Semantic Scholar
Efficacy of high-dose versus standard-dose influenza vaccine in older adults.
C. Diazgranados, Andrew J. Dunning, Murray A. Kimmel, Daniel Kirby +13 more
2014New England Journal of Medicine813 citations Open access
Semantic Scholar
Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
S. Sridhar, Alexander Luedtke, Edith Langevin, M. Zhu +19 more
2018New England Journal of Medicine692 citations Open access
Semantic Scholar
Prevention of Infection with Mycobacterium tuberculosis by H4:IC31® Vaccination or BCG Revaccination in Adolescents
E. Nemes, H. Geldenhuys, V. Rozot, K. Rutkowski +23 more
2018New England Journal of Medicine500 citations Open access
Semantic Scholar
The promise of mRNA vaccines: a biotech and industrial perspective
Nicholas A. C. Jackson, K. Kester, D. Casimiro, S. Gurunathan +1 more
2020npj Vaccines424 citations Open access
Semantic Scholar
Vaccination with DNA Encoding the Immunodominant LACK Parasite Antigen Confers Protective Immunity to Mice Infected with Leishmania major
S. Gurunathan, D. Sacks, D. Brown, Steven L. Reiner +3 more
1997Journal of Experimental Medicine413 citations Open access
Semantic Scholar
Accumulation of chlorpyrifos on residential surfaces and toys accessible to children.
S. Gurunathan, M. Robson, N. Freeman, B. Buckley +4 more
1998Environmental Health Perspectives308 citations Open access
Semantic Scholar
Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection
S. Gurunathan, C. Prussin, D. Sacks, R. Seder
1998Nature Medicine264 citations
Semantic Scholar
The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge.
Laura Stobie, S. Gurunathan, C. Prussin, D. Sacks +3 more
2000Proceedings of the National Academy of Sciences of the United States of America224 citations Open access
Semantic Scholar
Ad hoc analysis of behavior and time as co-variates of the Thai phase III efficacy trial: RV 144
M. Robb, S. Rerks-Ngarm, S. Nitayaphan, P. Pitisuttithum +16 more
2012Lancet. Infectious Diseases (Print)213 citations Open access
Semantic Scholar
The Thai Phase III HIV Type 1 Vaccine Trial (RV144) Regimen Induces Antibodies That Target Conserved Regions Within the V2 Loop of gp120
N. Karasavvas, E. Billings, M. Rao, C. Williams +33 more
2012AIDS Research and Human Retroviruses212 citations Open access
Semantic Scholar
Requirements for the Maintenance of Th1 Immunity In Vivo Following DNA Vaccination: A Potential Immunoregulatory Role for CD8+ T Cells
S. Gurunathan, Laura Stobie, C. Prussin, D. Sacks +6 more
2000Journal of Immunology164 citations Open access
Semantic Scholar
The Potency and Durability of DNA- and Protein-Based Vaccines Against Leishmania major Evaluated Using Low-Dose, Intradermal Challenge
S. Mendez, S. Gurunathan, S. Kamhawi, Y. Belkaid +6 more
2001Journal of Immunology161 citations Open access
Semantic Scholar
Quantitative analysis of children's microactivity patterns: The Minnesota Children's Pesticide Exposure Study
N. Freeman, M. Jimenez, K. J. Reed, S. Gurunathan +7 more
2001Journal of Exposure Analysis and Environmental Epidemiology142 citations Open access
Semantic Scholar
Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults.
S. Nitayaphan, P. Pitisuttithum, C. Karnasuta, C. Eamsila +17 more
2004Journal of Infectious Diseases141 citations
Semantic Scholar
A Methodology for Transforming an Existing Distribution Network Into a Sustainable Autonomous Micro-Grid
M. Kirthiga, S. Daniel, S. Gurunathan
2013IEEE Transactions on Sustainable Energy130 citations
Semantic Scholar
Primary Role for GI Protein Signaling in the Regulation of Interleukin 12 Production and the Induction of T Helper Cell Type 1 Responses
Jianping He, S. Gurunathan, A. Iwasaki, Belinda Ash-Shaheed +1 more
2000Journal of Experimental Medicine130 citations Open access
Semantic Scholar
Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand.
C. Karnasuta, R. Paris, J. Cox, S. Nitayaphan +9 more
2005Vaccine110 citations
Semantic Scholar
Failure of co-trimoxazole in Pneumocystis carinii infection and mutations in dihydropteroate synthase gene.
Qin Mei, S. Gurunathan, H. Masur, J. Kovacs
1998The Lancet107 citations
Semantic Scholar
Poxvirus-based vaccine candidates for HIV: two decades of experience with special emphasis on canarypox vectors
G. Franchini, S. Gurunathan, Lynn Baglyos, S. Plotkin +1 more
2004Expert Review of Vaccines105 citations
Semantic Scholar
Heterologous Human Immunodeficiency Virus Type 1 Priming-Boosting Immunization Strategies Involving Replication-Defective Adenovirus and Poxvirus Vaccine Vectors
D. Casimiro, A. Bett, T. Fu, M. Davies +10 more
2004Journal of Virology97 citations Open access
Semantic Scholar
Safety and immunogenicity of the pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine candidate in adults.
Thierry Kamtchoua, M. Bologa, R. Hopfer, D. Neveu +6 more
2013Vaccine95 citations
Semantic Scholar
A Phase 1/2 Comparative Vaccine Trial of the Safety and Immunogenicity of a CRF01_AE (Subtype E) Candidate Vaccine: ALVAC-HIV (vCP1521) Prime With Oligomeric gp160 (92TH023/LAI-DID) or Bivalent gp120 (CM235/SF2) Boost
P. Thongcharoen, V. Suriyanon, R. Paris, C. Khamboonruang +12 more
2007Journal of Acquired Immune Deficiency Syndromes95 citations
Semantic Scholar
Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study
P. Goepfert, B. Fu, Anne-Laure Chabanon, M. Bonaparte +18 more
2021Lancet. Infectious Diseases (Print)87 citations Open access
Semantic Scholar
An Analysis of Farmers' Perception and Awareness towards Crop Insurance as a Tool for Risk Management in Tamil Nadu
D. S. Kumar, B. Barah, C. Ranganathan, R. Venkatram +2 more
2011Agricultural Economics Research Review81 citations Open access
Semantic Scholar
Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine.
M. Bologa, Thierry Kamtchoua, R. Hopfer, Xiaohua Sheng +6 more
2012Vaccine80 citations
Semantic Scholar
Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults.
M. Seiberling, M. Bologa, R. Brookes, M. Ochs +6 more
2012Vaccine70 citations
Semantic Scholar
High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjects.
Paul A. Goepfert, H. Horton, M. McElrath, S. Gurunathan +13 more
2005Journal of Infectious Diseases68 citations Open access
Semantic Scholar
Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial.
G. de Bruyn, D. Gordon, T. Steiner, P. Tambyah +20 more
2020Lancet. Infectious Diseases (Print)65 citations
Semantic Scholar
Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E.
S. Rerks-Ngarm, R. Paris, S. Chunsutthiwat, Nakorn Premsri +23 more
2013Journal of Infectious Diseases65 citations Open access
Semantic Scholar
Safety and Reactogenicity of Canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E Vaccination in an Efficacy Trial in Thailand
P. Pitisuttithum, S. Rerks-Ngarm, V. Bussaratid, Jittima Dhitavat +19 more
2011PLoS ONE58 citations Open access
Semantic Scholar
House dust levels of selected insecticides and a herbicide measured by the EL and LWW samplers and comparisons to hand rinses and urine metabolites
P. Lioy, R. Edwards, N. Freeman, S. Gurunathan +4 more
2000Journal of Exposure Analysis and Environmental Epidemiology56 citations Open access
Semantic Scholar
Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres.
Stephanie Pepin, M. Dupuy, C. Borja-Tabora, May Montellano +14 more
2019Vaccine52 citations Open access
Semantic Scholar
HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers
E. McFarland, Daniel C Johnson, Petronella Muresan, T. Fenton +8 more
2006AIDS (London)52 citations Open access
Semantic Scholar
Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women.
Daniel C Johnson, E. McFarland, Petronella Muresan, T. Fenton +11 more
2005Journal of Infectious Diseases50 citations
Semantic Scholar
A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune
J. Angel, J. Routy, C. Tremblay, D. Ayers +7 more
2011AIDS (London)48 citations Open access
Semantic Scholar
BALB/c Mice Bearing a Transgenic IL-12 Receptor β2 Gene Exhibit a Nonhealing Phenotype to Leishmania major Infection Despite Intact IL-12 Signaling
R. Nishikomori, S. Gurunathan, Kanako Nishikomori, W. Strober
2001Journal of Immunology44 citations Open access
Semantic Scholar
Hybrid clinical trials to generate real-world evidence: design considerations from a sponsor's perspective.
M. Zhu, S. Sridhar, R. Hollingsworth, A. Chit +5 more
2020Contemporary Clinical Trials37 citations
Semantic Scholar
HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX(®) B/E.
R. Paris, S. Bejrachandra, P. Thongcharoen, S. Nitayaphan +11 more
2012Vaccine37 citations
Semantic Scholar
Use of predictive markers of HIV disease progression in vaccine trials.
S. Gurunathan, R. El Habib, Lynn Baglyos, C. Méric +4 more
2009Vaccine36 citations
Semantic Scholar
Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humans.
A. Bett, Sheri A. Dubey, D. Mehrotra, Liming Guan +14 more
2010Vaccine33 citations
Semantic Scholar
Lessons From a Multisite International Trial in the Caribbean and South America of an HIV-1 Canarypox Vaccine (ALVAC-HIV vCP1452) With or Without Boosting With MN rgp120
F. Cleghorn, J. Pape, M. Schechter, C. Bartholomew +15 more
2007Journal of Acquired Immune Deficiency Syndromes33 citations Open access
Semantic Scholar
Feasibility and Safety of ALVAC-HIV vCP1521 Vaccine in HIV- exposed Infants in Uganda: Results from the First HIV Vaccine Trial in Infants in Africa
K. Kintu, P. Andrew, P. Musoke, P. Richardson +11 more
2013Journal of Acquired Immune Deficiency Syndromes23 citations Open access
Semantic Scholar
Multidimensional analyses reveal modulation of adaptive and innate immune subsets by tuberculosis vaccines
V. Rozot, E. Nemes, H. Geldenhuys, M. Musvosvi +17 more
2020Communications Biology21 citations Open access
Semantic Scholar
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Recombinant Protein Vaccine with AS03 adjuvant in adults: a Phase 3, multi-country study
Gustavo H. Dayan, N. Rouphael, Stephen R. Walsh, Ai-Ying Chen +118 more
2023The Lancet Respiratory Medicine20 citations Open access
Semantic Scholar
Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodies
R. Brookes, Marin Ming, K. Williams, R. Hopfer +4 more
2015Human Vaccines & Immunotherapeutics18 citations Open access
Semantic Scholar
Short Communication: Human Immunodeficiency Virus Rebound in Blood and Seminal Plasma Following Discontinuation of Antiretroviral Therapy
C. Costiniuk, C. Kovacs, J. Routy, J. Singer +3 more
2012AIDS Research and Human Retroviruses18 citations Open access
Semantic Scholar
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study
G. de Bruyn, Joyce Wang, A. Purvis, Martin Sanchez Ruiz +34 more
2023EClinicalMedicine17 citations Open access
Semantic Scholar
Productivity and Profitability Impact of Genetically Modified Crops - An Economic Analysis of Bt Cotton Cultivation in Tamil Nadu
R. Loganathan, R. Balasubramanian, K. Mani, S. Gurunathan
200916 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Paris×8
Invite
R. Paris — researcher profile on SciRah
J. Tartaglia×8
Invite
J. Tartaglia — researcher profile on SciRah
P. Pitisuttithum×7
Invite
P. Pitisuttithum — researcher profile on SciRah
S. Nitayaphan×7
Invite
S. Nitayaphan — researcher profile on SciRah

×7

Invite

M. D. de Souza — researcher profile on SciRah

Jerome H. Kim×7

Invite

Jerome H. Kim — researcher profile on SciRah

P. Thongcharoen×6

Invite

P. Thongcharoen — researcher profile on SciRah

Invite

M. Robb — researcher profile on SciRah

Invite

R. Seder — researcher profile on SciRah

C. Diazgranados×6

Invite

C. Diazgranados — researcher profile on SciRah

S. Rerks-Ngarm×5

Invite

S. Rerks-Ngarm — researcher profile on SciRah

Invite

N. Michael — researcher profile on SciRah